期刊文献+

巨细胞病毒感染与冠心病患者的白细胞介素-10水平升高相关

Cytomegalovirus infection is associated with elevated interleukin-10 in coronary artery disease
下载PDF
导出
摘要 目的探讨CMV感染对冠心病患者血清IL-10的影响。方法冠心病患者106例和冠状动脉造影证实的冠状动脉光滑者82例作为对照,ELISA法检测特异性CMV IgG,双单抗夹心法定量测定血清IL-10水平。据研究个体的IL-10中位数水平(6.84 pg/ml)进行高、低IL-10分组,行单因素和多因素Logistic回归分析高水平IL-10的影响因素。结果冠心病组与对照组相比,CMVIgG阳性率差异不显著(38.9%vs.37.6%,P>0.05);冠心病组IL-10水平显著高于对照组,7.3(3.0-12.5)pg/ml vs.5.9(3.2-10.4)pg/ml(P=0.043)。高IL-10患者的CMV IgG阳性率显著高于低IL-10患者(46.8%vs.30.4%,P<0.001);在冠心病组,高IL-10组中的CMVIgG阳性率显著高于低IL-10组(48.1%vs.28.6%,P<0.001),而在冠状动脉光滑患者的高、低IL-10组中,未见CMV IgG阳性率的显著差异(40.4%vs.35.6%,P=0.588);IL-10升高相关因素的多元Logistic回归分析显示,在冠心病组,CMV IgG阳性与高IL-10独立相关,调整的OR值为2.3(1.6~3.4,P<0.001),而在对照组则为1.1(0.5~2.5,P=0.83)。调整变量包括年龄、性别、吸烟、高血压、血脂紊乱、糖尿病及较少体力活动。结论CMV感染与冠心病患者血清IL-10水平升高独立相关,在冠心病患者,CMV感染的免疫应答可能是一个影响细胞因子网络的复杂反应。 Objective Investigated the impact of CMV infection on serum IL-IO levels in patients with CAD. Methods Specific CMV IgG and serum levels of IL-IO were measured with ELISA in patients with CAD (n = 106) and smooth coronary artery controls documented angiographically (n =82). Subjects were dichotomized according to calculated median level of IL-10 (6.84 pg/ml) in different groups or sub- groups. Univariate and multivariate analyses were performed to analyse the contributors of high IL-10. Resuits The seropositivity of CMV IgG was not significantly different between CAD and control groups (38.9% vs. 37.6%, P 〉0.05). IL-10 level in the patients with CAD was higher than that in the controls [ 7.3 (3.0 -12.5) pg/ml vs. 5.9 (3.2 - 10.4) pg/ml, P = 0. 043 ]. The seropositivity of CMV IgG was more frequently found in the high IL-10 group than the low IL-10 group (46.8% vs. 30.4%, P 〈0. 001 ). The prevalence of CMV infection was significantly higher in the high IL-IO group than the low IL-10 group among the patients with CAD (48.1% vs. 28.6 % ,P 〈0.001 ), but not among the controls (40.4% vs. 35.6% ,P = O. 588 ). On multiple logistic regression analysis, the adjusted odds ratio of high IL-10 associated with CMV infection was 2.3 ( 1.6 - 3.4, P 〈 0. 001 ) in the patients with CAD, and 1.1 (0.5 - 2.5, P = 0. 83 ) in the controls. Conclusion We found a significant association of CMV infection with elevated IL- l0 in patients with CAD, but not in those with smooth coronary artery. Therefore, we propose that changes in the immune response to CMV are a compounding factor in CAD
出处 《环球中医药》 CAS 2010年第1期45-49,共5页 Global Traditional Chinese Medicine
关键词 冠心病 白细胞介素-10 巨细胞病毒 感染 Coronary artery disease Interleukin-lO Cytomegalovirus Infection
  • 相关文献

参考文献29

  • 1孙余华,裴卫东,吴永健,叶绍东,王国干,高润霖,杨跃进.肺炎衣原体感染增加血脂紊乱者患冠心病的危险性[J].中华医学杂志,2004,84(23):1990-1993. 被引量:4
  • 2Sun Y,Pei W,Wu Y,et al.An association of herpes simplex virus type 1 infection with type 2 diabetes. Diabetes Care . 2005
  • 3Libby P,Ridker PM,Maseri A.Inflammation and Atherosclerosis. Circulation . 2002
  • 4Ross R.Atherosclerosis-an inflammatory disease. New England Journal of Homeopathy . 1999
  • 5Moore K W,de Waal Malefyt R,Coffman R L,et al.Interleukin-10 and the interleukin-10 receptor. Annual Review of Immunology . 2001
  • 6Moore K W,Vieira P,Fiorentino P D,et al.Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science . 1990
  • 7Fiorentino DF,Bond MW,Mosmann TR,et al.Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. The Journal of Experimental Medicine . 1989
  • 8Lacraz S,Nicod LP,Chicheportiche R,et al.IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. The Journal of Clinical Investigation . 1995
  • 9Lindmark E,Tenno T,Chen J,et al.IL-10 inhibits LPS-induced human monocyte tissue factor expression in whole blood. British Journal of Haematology . 1998
  • 10Pinderski LJ,Fischbein MP,Subbanagounder G,et al.Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes. Circulation Research . 2002

二级参考文献15

  • 1Epstein SE. The multiple mechanisms by which infection may contribute to atherosclerosis development and course. Circ Res, 2002,90:2-4.
  • 2Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation,2002,105:1135-1143.
  • 3Leinonen M, Saikku P. Evidence for infectious agents in cardiovascular disease and atherosclerosis. Lancet Infect Dis, 2002,2:11-17.
  • 4Danesh J, Whincup P, Lewington S, et al. Chlamydia pneumoniae IgA titres and coronary heart disease: prospective study and meta-analysis. Eur Heart J,2002,23:371-375.
  • 5Hu H, Pierce GN, Zhong G. The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J Clin Invest,1999,103:747-753.
  • 6Ezzahiri R, Nelissen-Vrancken HJ, Kurvers HA, et al. Chlamydophila pneumoniae (Chlamydia pneumoniae) accelerates the formation of complex atherosclerotic lesions in Apo E3-Leiden mice. Cardiovasc Res, 2002,56:269-276.
  • 7Rothstein NM, Quinn TC, Madico G, et al. Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae. J Infect Dis,2001,183:232-238.
  • 8Blessing E, Campbell LA, Rosenfeld ME, et al. Chlamydia pneumoniae and hyperlipidemia are co-risk factors for atherosclerosis: infection prior to induction of hyperlipidemia does not accelerate development of atherosclerotic lesions in C57BL/6J mice. Infe
  • 9Huittinen T, Leinonen M, Tenkanen L, et al. Synergistic effect of persistent Chlamydia pneumoniae infection, autoimmunity, and inflammation on coronary risk. Circulation,2003,107:2566-2570.
  • 10Kontula K, Vuorio A, Turtola H, et al. Association of seropositivity for Chlamydia pneumonlae and coronary artery disease in heterozygous familial hypercholesterolaemia. Lancet,1999,354:46-47.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部